This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of nasal cavity and middle ear
C3_NASAL_CAVITY_MIDDLE_EAR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
192 |
4. Check minimum number of eventsNone |
192 |
5. Include endpointsNone |
192 |
6. Filter based on genotype QC (FinnGen only) |
171 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasal cavity and middle ear
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasal cavity and sinuses
- Malignant neoplasm of nasal cavity and middle ear, including Hilmo
- Malignant neoplasm of nasal cavity and sinuses, including Hilmo
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 171 | 67 | 104 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | 65.43 | 64.53 | 66.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 180
- Matched controls
- 1800
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
152.6
124
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
22.2
87.7
78
60
130
Kela drug reimbursment
Malignant tumour
+∞
69.3
62
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
143.7
64.0
65
7
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
191.9
63.7
63
5
XX3DW
NOMESCO Finland
Time consuming IT work
19.4
62.4
55
40
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
61.0
55
*
A04AA01
ATC
ondansetron; systemic, rectal
29.0
55.2
39
17
H02AB02
ATC
dexamethasone; systemic
191.2
54.3
54
*
DHB10
NOMESCO Finland
Excision of lesion of internal nose
+∞
52.7
48
*
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
51.6
47
*
WF002
NOMESCO Finland
Radical radiotherapy
606.9
48.8
46
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.6
42.5
72
129
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
239.0
38.4
38
*
WZC00
NOMESCO Finland
Treatment plan or consultation
6.9
38.3
101
280
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
35.6
33
*
Z51.5
ICD-10 Finland
Palliative care
13.0
35.2
37
35
A04AA02
ATC
granisetron; systemic, transdermal
405.2
34.1
33
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
15.4
34.1
32
25
EP1AE
NOMESCO Finland
Neck ultrasound examination
14.2
33.5
33
28
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
32.3
30
*
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
31.1
29
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
30.0
28
*
R04.0
ICD-10 Finland
Epistaxis
7.7
29.0
48
81
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
26.7
25
*
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
26.7
25
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
26.7
25
*
N02AA05
ATC
oxycodone; systemic
5.8
25.9
62
150
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
10.1
24.4
30
35
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
26.6
24.1
33
15
WF049
NOMESCO Finland
Radiotherapy of metastasis
262.0
23.2
23
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
22.4
21
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
131.0
22.1
23
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
249.0
22.1
22
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
21.3
20
*
UDM02
NOMESCO Finland
Sinoscopy
26.3
21.2
29
13
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
20.2
19
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
23.4
19.8
28
14
ZX090
NOMESCO Finland
Other technic of radiotherapy
78.6
19.1
21
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
19.1
18
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
111.9
19.0
20
*
L03AA02
ATC
filgrastim; parenteral
211.1
18.9
19
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.6
18.5
33
59
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
59.0
18.4
21
*
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
+∞
18.0
17
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
+∞
16.9
16
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
16.9
16
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
99.5
16.9
18
*
WX402
NOMESCO Finland
General anaesthesia
4.2
16.8
59
188
ZXE30
NOMESCO Finland
More than five and less than seven hours
13.6
16.2
28
24
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
15.9
15
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
15.9
15
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.9
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
15.8
67
243
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.2
15.0
28
52
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.8
15.0
39
98
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
14.8
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
14.8
14
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
14.8
14
*
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
14.8
14
*
DPA30
NOMESCO Finland
Sphenotomy
39.7
14.7
18
5
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
162.7
14.7
15
*
DHB40
NOMESCO Finland
Conchotomy
162.7
14.7
15
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
13.0
14.3
25
22
ZXE20
NOMESCO Finland
More than three and less than five hours
4.3
14.1
43
122
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
13.7
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.7
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
13.7
13
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
13.7
13
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
150.9
13.6
14
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
24.8
13.2
18
8
ZZR00
NOMESCO Finland
Flap of skin
+∞
12.6
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
12.6
12
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
12.6
12
*
A07AA02
ATC
nystatin; oral
5.8
12.6
25
49
JN4BD
NOMESCO Finland
Extensive body CT
6.1
12.5
23
42
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.1
12.4
91
450
JN4AD
NOMESCO Finland
Body CT examination
5.6
12.3
25
50
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
11.6
11
*
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
11.6
11
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
11.6
11
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
11.6
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.0
11.5
87
433
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
46.4
11.1
13
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
19.3
10.9
16
9
ZX120
NOMESCO Finland
Intravenous
5.0
10.9
25
56
JDB10
NOMESCO Finland
Percutaneous gastrostomy
63.9
10.8
12
*
EBA10
NOMESCO Finland
Operative extraction of tooth
4.3
10.7
31
84
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.5
10
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
10.5
10
*
DHB01
NOMESCO Finland
Partial excision of external nose
+∞
10.5
10
*
L01CB01
ATC
etoposide; systemic
+∞
10.5
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
+∞
10.5
10
*
L03AA13
ATC
pegfilgrastim; parenteral
58.2
9.8
11
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
58.2
9.8
11
*
WZC30
NOMESCO Finland
Teaching
3.6
9.7
36
116
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.5
9.6
38
128
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
105.3
9.5
10
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.5
9
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
9.5
9
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
+∞
9.5
9
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
9.5
9
*
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
+∞
9.5
9
*
DLW99
NOMESCO Finland
Other plastic operations on nose
+∞
9.5
9
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.5
9.3
24
59
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
16.7
9.2
14
9
ZXE40
NOMESCO Finland
More than seven and less than nine hours
38.8
9.1
11
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
10.3
9.0
17
18
XW000
NOMESCO Finland
Bone marrow biopsy
11.6
9.0
16
15
ZXA05
NOMESCO Finland
Left side
2.8
8.9
62
288
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
52.6
8.8
10
*
ZXC95
NOMESCO Finland
Use of surgical navigator
17.4
8.7
13
8
J33.0
ICD-10 Finland
Polyp of nasal cavity
8.2
8.4
18
24
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
8.4
8
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
8.4
8
*
8072/3-C30.0
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasal cavity
+∞
8.4
8
*
8020/3-C30.0
ICD-O-3
Carcinoma, undifferentiated, NOS, of nasal cavity
+∞
8.4
8
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
8.4
8
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
+∞
8.4
8
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
10.8
8.2
15
15
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
23.3
8.1
11
5
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.7
8.0
53
239
R4190
NOMESCO Finland
Nutritional therapy
9.5
7.7
15
17
J33.9
ICD-10 Finland
Nasal polyp, unspecified
19.4
7.7
11
6
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
7.4
18
42
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
7.3
7
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
WX110
NOMESCO Finland
Infiltration anesthesia
2.5
7.2
129
903
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
31.4
7.2
9
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
7.5
7.2
16
23
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
7.0
29
100
WW500
NOMESCO Finland
Blood transfusion
9.9
6.9
13
14
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
23.5
6.7
9
*
H65.2
ICD-10 Finland
Chronic serous otitis media
12.9
6.7
11
9
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
6.6
29
103
K11.70
ICD-10 Finland
Hypoptyalism
72.3
6.5
7
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
72.3
6.5
7
*
DKW40
NOMESCO Finland
Ligature of artery of internal nose
72.3
6.5
7
*
SPF20
NOMESCO Finland
Temporary relining of dentures
72.3
6.5
7
*
UDC00
NOMESCO Finland
Ear microscopy
3.3
6.4
26
88
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
18.8
6.3
9
5
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
6.3
61
324
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
DCB00
NOMESCO Finland
Excision of lesion of middle ear
+∞
6.3
6
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
ZZR50
NOMESCO Finland
Mucoperiosteal flap
+∞
6.3
6
*
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
+∞
6.3
6
*
8200/3-C30.0
ICD-O-3
Adenoid cystic carcinoma of nasal cavity
+∞
6.3
6
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
27.7
6.3
8
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
6.2
69
389
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
5.6
6.2
17
33
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
6.2
46
217
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
119
617
3.74
16.15
3.8
2.4
—
—
estimate
—
0
0
128
728
3.62
14.35
7.4
6.5
1.20
1.21
mmol/l
0.43
109
640
132
777
3.62
13.75
15.5
6.3
3.93
4.32
e9/l
1.25
116
668
21
41
5.67
10.60
2.1
2.5
1.07
1.71
mg/l
3.54
21
34
15
9
18.03
10.06
1.3
1.0
—
—
—
0
0
17
16
11.60
9.51
1.4
1.1
287.06
261.64
mosm/kgh2o
1.20
17
11
15
12
13.51
9.05
1.5
1.2
17.68
22.62
ng/l
0.54
15
12
62
321
2.42
6.89
2.4
2.0
—
—
—
0
0
11
12
9.67
5.87
1.2
1.2
—
—
—
0
0
15
29
5.54
5.53
1.2
1.5
—
—
—
0
0
40
187
2.46
5.43
6.8
7.8
0.81
1.02
mmol/l
0.10
30
163
28
114
2.72
5.01
3.8
1.9
74.67
65.34
ml/min/173m2
0.64
15
41
37
174
2.42
4.94
2.3
1.9
—
—
—
0
0
39
189
2.36
4.87
2.2
1.8
—
—
—
0
0
16
48
3.56
4.73
1.9
4.4
—
—
—
0
0
11
18
6.43
4.68
1.2
1.3
—
—
—
0
0
8
9
9.23
4.32
1.6
2.4
—
—
—
0
0
65
402
1.97
4.31
2.7
3.2
0.24
0.39
e6/l
0.71
45
292
42
222
2.16
4.24
6.1
6.6
103.55
104.74
mmol/l
0.73
42
222
8
10
8.31
4.10
1.6
2.0
15.88
13.00
%
—
8
10
8
10
8.31
4.10
1.9
2.2
—
—
—
0
0
6
5
12.34
3.79
3.2
2.0
4.45
6.94
nmol/l
—
6
5
24
105
2.48
3.72
1.3
1.5
—
—
—
0
0
29
141
2.26
3.56
5.5
3.2
—
—
—
0
0
42
241
1.97
3.37
2.4
1.8
—
—
—
0
0
124
1432
0.57
2.91
4.3
5.6
1.37
1.42
mmol/l
0.69
116
1329
7
13
5.55
2.90
1.9
1.1
—
—
—
0
0
113
898
1.69
2.89
4.2
4.5
902.00
298.08
e6/l
—
7
13
135
1134
1.76
2.74
30.6
18.2
14.31
13.59
%
5.53
135
1121
10
29
3.59
2.74
1.7
1.6
—
—
—
0
0
118
1374
0.59
2.73
3.8
4.7
1.38
1.30
mmol/l
0.57
107
1259
11
35
3.28
2.69
1.5
1.5
—
—
—
0
0
9
25
3.73
2.61
1.9
1.3
—
—
—
0
0
11
37
3.10
2.54
1.5
1.2
—
—
—
0
0
126
1436
0.59
2.52
4.6
5.7
4.55
4.47
mmol/l
0.41
118
1339
158
1406
2.01
2.48
27.2
14.4
28.61
24.34
mg/l
0.70
141
1125
10
32
3.25
2.48
2.3
2.4
3.55
3.90
g/l
—
10
32
5
8
6.39
2.38
2.4
1.0
—
—
—
0
0
40
593
0.58
2.37
4.2
4.3
7.61
7.14
mg/mmol
0.03
25
396
8
23
3.59
2.30
1.9
1.3
—
—
—
0
0
9
29
3.21
2.26
2.2
1.6
—
—
—
0
0
9
30
3.10
2.18
1.8
1.5
—
—
—
0
0
9
30
3.10
2.18
1.9
1.2
—
—
—
0
0
130
1455
0.62
2.11
5.0
6.6
2.62
2.59
mmol/l
0.16
119
1353
48
330
1.62
2.05
3.5
4.4
173.64
373.20
ng/l
0.53
42
271
57
409
1.58
2.04
4.4
2.4
328.46
360.55
umol/l
1.80
52
352
17
301
0.52
1.82
1.1
1.3
9.44
1.81
u/ml
—
5
76
8
31
2.65
1.68
2.5
1.9
85.50
91.68
%
—
8
31
8
31
2.65
1.68
1.1
1.5
—
—
—
0
0
6
19
3.23
1.67
1.2
1.7
—
—
—
0
0
22
129
1.80
1.66
2.6
4.1
102.77
218.09
ng/l
1.73
22
115
7
26
2.76
1.59
2.0
1.2
—
—
—
0
0
52
395
1.45
1.37
1.9
2.1
2.82
2.66
mg/l
0.28
47
334
16
92
1.81
1.30
1.1
1.3
17.00
135.43
u/ml
—
5
33
5
18
2.83
1.29
1.6
2.1
—
141.26
—
0
5
123
1096
1.39
1.22
4.8
4.3
16.69
11.67
mm/h
2.99
118
1015
18
110
1.71
1.21
8.8
9.4
0.67
0.72
%
0.18
18
110
26
176
1.56
1.19
2.6
3.2
5.99
5.75
kpa
0.69
26
171
144
1321
1.45
1.18
5.5
5.2
2.20
1.97
mu/l
0.85
137
1200
7
31
2.31
1.11
2.9
2.1
216.29
178.29
%
—
7
31
6
122
0.47
1.10
3.0
2.3
2.98
3.53
ratio
—
6
105
5
21
2.42
1.10
2.8
1.7
—
—
—
0
0
5
21
2.42
1.10
2.8
1.7
—
—
—
0
0
5
21
2.42
1.10
2.0
1.7
—
—
—
0
0
5
21
2.42
1.10
1.0
1.1
—
—
—
0
0
27
374
0.67
1.09
2.7
2.7
0.75
0.69
ug/l
0.16
21
234
61
733
0.75
1.05
2.2
2.1
92.63
95.40
pmol/l
0.17
34
352
25
176
1.49
0.97
2.6
3.1
2.82
1.72
mmol/l
1.38
25
146
32
237
1.43
0.97
1.9
2.5
15.56
12.72
umol/l
0.39
32
217
53
641
0.75
0.94
1.7
2.0
1.45
1.35
mmol/l
0.49
47
536
147
1373
1.39
0.91
25.7
14.3
81.19
77.62
ml/min/173m2
1.55
139
1275
50
405
1.32
0.88
3.4
3.8
0.00
0.00
estimate
-0.00
20
126
30
225
1.40
0.85
1.8
2.5
2.35
2.22
g/l
0.65
30
206
10
57
1.80
0.85
5.5
1.2
9.70
10.03
g/l
—
10
49
133
1420
0.76
0.84
4.9
5.6
6.04
6.08
mmol/l
0.14
124
1301
20
278
0.68
0.83
1.2
1.3
14.20
39.39
iu/ml
—
5
88
17
115
1.53
0.80
9.0
9.2
1.39
1.38
%
0.02
17
115
14
91
1.58
0.78
2.1
1.5
—
—
—
0
0
85
761
1.22
0.64
3.3
3.8
0.00
0.00
estimate
-0.00
21
141
27
210
1.34
0.63
1.9
2.5
27.74
22.86
%
0.39
27
195
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
8
53
1.53
0.59
6.5
1.2
0.00
0.00
g/l
—
8
48
49
418
1.24
0.58
3.6
3.4
0.00
0.00
estimate
-0.00
18
116
160
1540
1.35
0.57
37.4
22.2
4.23
4.53
e12/l
8.90
155
1503
160
1541
1.34
0.56
37.6
22.3
126.03
137.05
g/l
13.65
160
1522
31
251
1.28
0.56
2.9
2.9
0.62
1.13
e6/l
0.82
13
128
83
750
1.20
0.55
3.3
3.8
0.00
0.00
estimate
-0.00
21
138
66
586
1.20
0.52
3.3
3.7
0.00
0.00
estimate
-0.00
16
111
10
67
1.52
0.51
5.5
1.3
2.54
2.88
g/l
—
10
59
29
237
1.27
0.49
3.1
3.1
0.00
1.97
e6/l
3.08
11
112
84
771
1.17
0.44
3.4
3.9
0.00
0.03
estimate
0.50
20
126
17
131
1.33
0.44
2.7
2.4
0.43
0.24
e6/l
0.54
17
123
6
91
0.65
0.43
2.5
2.1
2.57
3.56
mmol/l
—
6
75
134
1398
0.84
0.43
5.8
7.4
40.39
40.17
mmol/mol
0.10
124
1311
10
70
1.45
0.42
5.5
1.3
6.13
7.51
g/l
—
10
62
10
70
1.45
0.42
5.5
1.3
4.50
4.38
g/l
—
10
62
10
70
1.45
0.42
5.5
1.3
3.67
3.68
g/l
—
10
62
15
114
1.34
0.42
4.6
1.9
64.91
66.62
g/l
0.43
15
104
8
61
1.33
0.40
7.0
1.2
0.43
0.32
g/l
—
8
53
83
770
1.14
0.36
2.8
2.8
—
—
—
0
0
6
44
1.38
0.35
1.2
1.1
—
—
—
0
0
6
45
1.34
0.34
1.0
1.2
—
—
—
0
0
38
338
1.16
0.29
1.5
1.7
3.01
0.92
mg/l
1.42
33
261
16
189
0.83
0.23
1.1
1.5
—
—
—
0
0
12
97
1.25
0.23
1.7
1.9
—
—
—
0
0
5
42
1.20
0.21
1.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
4.0
—
16.24
—
0
11
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
42.46
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
21
185
1.15
0.19
11.5
6.8
—
—
—
0
0
39
362
1.10
0.16
2.9
3.8
1.02
1.02
kg/l
0.05
28
233
9
80
1.13
0.15
2.3
1.6
—
—
—
0
0
26
284
0.90
0.14
1.4
1.7
1151.99
1206.86
nmol/l
0.13
21
210
10
85
1.19
0.12
1.5
1.8
—
—
—
0
0
5
44
1.14
0.10
1.8
2.0
—
—
—
0
0
65
671
0.95
0.09
3.8
4.0
912.63
45.56
ng/l
0.48
50
500
5
62
0.80
0.08
1.0
2.9
29.60
42.21
u/l
—
5
56
11
122
0.90
0.07
1.2
1.4
—
—
—
0
0
10
89
1.13
0.07
1.8
2.4
0.56
0.60
%
—
10
89
52
533
0.97
0.04
4.6
3.7
24.33
24.28
%
0.01
29
238
15
141
1.07
0.03
2.3
2.7
4.36
4.58
kpa
0.13
15
134
10
94
1.07
0.01
1.8
2.4
0.84
1.31
%
—
10
94
68
674
1.01
0.00
4.4
4.1
3.55
1.81
ug/l
0.58
63
597
15
147
1.02
0.00
1.5
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
0.48
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
2.8
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
57.01
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
5.1
—
657.88
—
0
8
0
9
0.00
-0.00
0.0
1.0
—
41.33
—
0
9
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
65.33
—
0
8
5
59
0.84
-0.00
3.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
9.33
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NASAL_CAVITY_MIDDLE_EAR – Malignant neoplasm of nasal cavity and middle ear
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).